AKRX News 35.57 08/13/2014 04:29:21 Akorn Inc (AKRX)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Akorn Inc (AKRX) 35.57 $AKRX

SmarTrend Watching for Potential Pullback in Shares of Akorn After 1.63% Gain
Comtex SmarTrend(R) - Tue Aug 12, 4:48PM CDT
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $34.57 to a high of $35.62. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $35.39 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Akorn Completes Acquisition of VersaPharm
GlobeNewswire - Tue Aug 12, 8:02AM CDT
Akorn, Inc. (Nasdaq:AKRX), a niche pharmaceutical company, announced today that it has completed its previously announced acquisition of VPI Holdings Corp., the parent company of VersaPharm Incorporated, for $440 million.

Relypsa (RLYP) Worth Watching: Stock Gains 13.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 11, 8:46AM CDT
Relypsa (RLYP) was a big mover last session, with shares rising over 13% on the day.

Zacks Rank #1 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 11, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday

Why Akorn (AKRX) Might Be a Diamond in the Rough - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 11, 7:34AM CDT
Akorn’s small price movement but large earnings estimate revisions make it an unappreciated stock that might have potential for gains

Akorn: the Pharmaceutical Stock You Can’t Afford to Ignore
at The Street - Fri Aug 08, 11:18AM CDT
You may have never heard of Akorn, but investors in this pharmaceutical company have been richly rewarded in recent years.

Shares of AKRX Up 37.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 08, 9:14AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 4 months, Akorn has returned 37.39% as of today's recent price of $33.73.

Akorn Trading Goes Wild On Q2 Report, Finds Support
at Investor's Business Daily - Thu Aug 07, 5:02PM CDT
Drugmaker Akorn has been through a volatile week since it reported better-than-expected quarterly earnings and revenue and raised guidance. Akorn (AKRX) stock initially shot higher on the news, announced before the open Tuesday, but gave back the...

Apple, Lithia Motors Test Key Support Areas
at Investor's Business Daily - Thu Aug 07, 5:02PM CDT
Most stocks will follow the direction of the general market. And now that the market is in a correction, look for leading stocks to pull back and digest gains. One key area to watch for is the 10-week moving average. The line can offer support and...

Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed
PR Newswire - Thu Aug 07, 8:20AM CDT
On Wednesday, August 6, 2014, the NASDAQ Composite ended at 4,355.05, up 0.05%, the Dow Jones Industrial Average advanced 0.08%, to finish the day at 16,443.34, and the S&P 500 closed the day flat at 1,920.24. The losses were broad based as six out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 700.41, down 0.12%, while the index has advanced 5.09% in the previous three months. Investor-Edge has initiated coverage on the following equities: Theravance Inc. (NASDAQ: THRX), Akorn Inc. (NASDAQ: AKRX), Endo International PLC (NASDAQ: ENDP), Pernix Therapeutics Holdings Inc. (NASDAQ: PTX), and Depomed Inc. (NASDAQ: DEPO). Free research on these five companies can be accessed at:

Stocks Sag In Rising Trade; Archer Daniels And Avis Rise
at Investor's Business Daily - Tue Aug 05, 9:39AM CDT
Stocks stubbornly held their opening losses Tuesday, despite some strong factory orders and service-sector data. The Nasdaq and S&P 500 dipped 0.5% each. The Dow Jones industrial average slipped 3%. Small caps lagged the pack, with the Russell 2000...

Actavis Guidance Disappoints; Akorn Beats And Raises
at Investor's Business Daily - Tue Aug 05, 9:29AM CDT
Specialty drugmakers and IBD 50 stocks Actavis (ACT) and Akorn were headed in opposite directions in the stock market today after the companies reported their second-quarter earnings and updated their guidance. Actavis' earnings rose 70% over the...

Stock Futures Grope Lower; Gannett Surges On Plan To Split
at Investor's Business Daily - Tue Aug 05, 8:02AM CDT
Stock futures ticked lower early Tuesday as a weak services sector report out of China rattled China-based stocks in the U.S. Dow futures dived 66.3 points below fair market value and were still dropping. Nasdaq 100 futures were off a sharp 19.3...

Why Akorn (AKRX) Stock Is Advancing Today
at The Street - Tue Aug 05, 7:26AM CDT
Shares of Akorn (AKRX) are up after the pharmaceutical company won U.S. antitrust approval to buy specialty prescription drug company VersaPharm.

Akorn Reports Preliminary 2014 Second Quarter Results
GlobeNewswire - Tue Aug 05, 5:36AM CDT
Akorn, Inc. (Nasdaq:AKRX), a niche generic pharmaceutical company, today reported preliminary financial results for the second quarter ended June 30, 2014.

Stocks Close Higher But Volume Declines
at Investor's Business Daily - Mon Aug 04, 3:19PM CDT
The stock market rebounded Monday, with the major indexes closing near session highs. The Nasdaq added 0.7% after the composite found support around its 50-day moving average. The S&P 500 also rose 0.7%, while the Dow Jones industrial average climbed...

Salix, Actavis Lead IBD 50 Drug Earnings This Week
at Investor's Business Daily - Sat Aug 02, 7:02AM CDT
Salix Pharmaceuticals (SLXP), which announced its tax inversion merger last month, will be among several IBD 50 drug stocks to report earnings this week. In July, Salix announced plans to merge with Italy's Cosmo Pharmaceuticals' Irish subsidiary,...

Akorn Shares Up 38.2% Since SmarTrend's Buy Recommendation (AKRX)
Comtex SmarTrend(R) - Thu Jul 31, 5:16PM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 38.21% as of today's recent price of $33.93.

Global Parkinson's Disease Market 2014-2018: Key Vendors are Boehringer Ingelheim, GlaxoSmithKline, Novartis and Teva
M2 - Thu Jul 31, 5:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l95k93/global) has announced the addition of the "Global Parkinson's Disease Market 2014-2018" report to their offering. Parkinson's disease is a progressive neurodegenerative disorder characterized by damage of dopaminergic neurons located in various parts of brain including the substantia nigra. This lowers the concentration of dopamine in the striatum. A decrease in dopamine levels by 80 percent leads to the development of symptoms associated with Parkinson's disease such as tremor, bradykinesia, and muscular rigidity. It is usually diagnosed in the population aged 60 and over; however, earlier incidences have been reported. Based on the severity, it can be categorized into early stage, mid stage and late (or advanced) stage. Currently, the approved therapies provide only symptomatic relief. Levodopa is the standard drug for the treatment of Parkinson's disease; however, it is associated with the incidence of dyskinesias. Alternative surgical procedures such as bilateral globus pallidus interna stimulation and bilateral subthalamic nucleus stimulation can be used in Parkinson's disease patients under certain circumstances. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by MOA 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Late-Stage Pipeline Candidates 18. Other Prominent Vendors 19. Key Vendor Analysis 20. Other Reports in this Series Companies Mentioned: - Boehringer Ingelheim GmbH - GlaxoSmithKline plc - Novartis AG - Teva Pharmaceutical Industries Ltd. - Abbvie Inc. - Akorn Inc. - Astellas Pharma Inc. - Desitin Arzneimittel GmbH - Endo International plc - F. Hoffmann-La Roche Ltd. - H. Lundbeck A/S - Kyowa Hakko Kirin - Merck & Co. Inc. - Orion Corp. - STADA Arzneimittel AG - UCB Inc. - US WorldMeds LLC - Valeant Pharmaceuticals International Inc. For more information visit http://www.researchandmarkets.com/research/l95k93/global

Uptrend Call Working As Akorn Stock Rises 41.5% (AKRX)
Comtex SmarTrend(R) - Thu Jul 24, 4:41PM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 41.47% as of today's recent price of $34.73.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZAKSIMLAB Tests Kombucha and Salmon Snack Pairing in Cafes

Updated Category News Views 48

A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 135

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 189

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Scalefusion’s Platinum Win Sharpens Its Brand Story

Updated Category News Views 14

A Film Is Not a Balance Sheet A slick brand film cannot patch a leaky product, but it can make a complicated platform easier to remember. That is the sensible takeaway from Scalefusion’s Platinum Level win at the 2026 MarCom Awards for “One Platform. One Agent. We are Scalefusion.” The recognition is for creative execution, not commercial performance, and anybody...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 194

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 81

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 89

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 237

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading

Top 5 Most Recently Viewed Articles

Olo Inc. Under Investigation for Potential Fiduciary Violations

Updated Category News Views 255

Olo Inc. Faces Investigation Over Fiduciary Duties Olo Inc. is currently under investigation by legal authorities due to possible breaches of fiduciary duty by its directors and management. This scrutiny follows Olo's announcement regarding a major acquisition deal with investment firm Thoma Bravo, valued at around $2 billion. Details of the Investigation The focus of the...

Continue Reading
Join MT Højgaard Holding's Conference Call on FY 2024 Results

Updated Category News Views 115

MT Højgaard Holding A/S Conference Call Overview MT Højgaard Holding is set to release its annual report for the fiscal year 2024 on a chosen date. Following this release, a conference call will take place where the management team will delve into the company’s performance and projections for the future. This session aims to provide insights into the results for the...

Continue Reading
ClearValue Consulting Partners with Restb.ai for Advanced Appraisals

Updated Category News Views 77

Unlocking Efficiency in Appraisal Reviews ClearValue Consulting, a leader in innovative valuation solutions, has announced an exciting new partnership with Restb.ai, a prominent name in AI-powered computer vision. This collaboration is set to redefine the appraisal review landscape, bringing in advanced technologies to streamline processes and enhance quality. The Impact...

Continue Reading
BrightSphere's Transformation: New Name and Leadership Direction

Updated Category News Views 393

BrightSphere Investment Group Inc. (NYSE: BSIG) announced its rebranding to Acadian Asset Management back in early 2025, marking a major shift in strategy. This wasn't just a name change; it was the end of their multi-boutique model and the start of a more streamlined focus on asset management. They offloaded six out of seven affiliates to zero in on core...

Continue Reading
Why Super Micro Computer’s Growth Could Still Continue

Updated Category News Views 339

Super Micro Computer (NASDAQ: SMCI) kicked off 2024 like a rocket, watching its stock explode by an eye-popping 188% in the first half. It was a remarkable performance that even left tech giants scrambling for a second look. The surge stemmed largely from surging demand for their cutting-edge workstations and servers—essential cogs in the booming artificial intelligence...

Continue Reading